None listed
Conditions
Interventions
Intervention1: Eye Make-up remover/Make-up remover: Frequency of Use: Once daily
Quantity of usage per application/dose: Approximately 5-7 drops
A 14 days study
Control Intervention1: NIL: NIL
Sponsors
ITC Life Science and Technology Centre
Eligibility
Inclusion criteria
Inclusion criteria: • Female adult subjects in general good health as determined from a recent medical history. • Subjects in the age group of 18-40 years (both ages inclusive). • Subject with various eye conditions such as normal condition, sensitive condition and contact lens users in nearly equal ratio. • Subjects willing to give a voluntary written informed consent, photography release and agree to come for regular follow up. • Subjects willing to abide by and comply with the study protocol. • Subjects who have not participated in a similar investigation in the past four weeks. • Subjects who are willing not to participate in any other clinical study during participation in the current study.
Exclusion criteria
Exclusion criteria: • A known history or present condition of allergic response to any cosmetic products (eye/ facial cosmetic products). • Subjects having eye infection or allergy. • Subjects having extremely sensitive eye condition. • Subjects having allergy to astringent based products. • Subjects who are using any eye drops or artificial tear drops. • Cutaneous disease which may influence the study result. • Subjects on oral medications (e.g. steroids, anti-oxidant) which will compromise the study. • Systemic treatment which may modify the cutaneous state on the day of inclusion or in the previous 30 days, including retinoid therapy. • Subjects who are pregnant, lactating or nursing. • Subject participating in any other cosmetic or therapeutic trial. • Any underlying uncontrolled medical illness including diabetes mellitus, hypertension, liver disease or history of alcoholism, HIV, hepatitis, or any other serious medical illness as determined by the medical history.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the safety of the test product in causing no ocular irritation on repeated use involving healthy female subjects of varied eye conditions such as normal condition, sensitive condition and contact lens usersTimepoint: Approximately 14 days for each subject. | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the dermatological safety of the test productTimepoint: Day1,Day2,Day3,Day4,Day5,Day7,Day10,Day14 | — |
Countries
India
Contacts
Public ContactDrGeethaS
MS Clinical Research Pvt,Ltd
Outcome results
None listed